{
    "nctId": "NCT05458739",
    "briefTitle": "The ClearCoast\u2122 Magnetic Resonance Outcome PMS Study",
    "officialTitle": "The ClearCoast\u2122 Magnetic Resonance Outcome Post Marketing Surveillance Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 93,
    "primaryOutcomeMeasure": "ClearCoast\u2122 Success rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women histologically diagnosed with invasive and/or in situ carcinoma of the breast, undergoing primary lumpectomy (partial mastectomy) procedure\n2. Age \u226518\n3. Patient is willing and capable to provide written Informed Consent Form (ICF)\n\n   Exclusion Criteria:\n4. Prior surgical procedure in the same breast within 12 months prior to the surgery date\n5. Recurrent breast cancer surgery\n6. Neoadjuvant chemotherapy and/or neoadjuvant hormone therapy\n7. Previous radiation therapy in the operated breast\n8. Pregnancy\n9. Lactation\n10. Patient has subglandular breast implants in the operated breast\n11. moribund patient and/or patient with comorbidities, per principal investigator discretion\n12. Participating in any other investigational study for either drug or device which might influence collection of valid data under this study.\n\n    Intraoperative:\n13. Specimen undergoing pathological specimen assessment (e.g. by frozen section, imprint cytology or gross assessment by sectioning), resulting in deformation of specimen shape/tissue properties (e.g. Formalin conservation)\n14. Specimen dimension is larger than the Tissue container volume (200cc)\n15. Inability to define aspect color/orientation and/or margin border",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}